Cargando…
Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model
Cervical cancer continues to impose a heavy burden worldwide, and human papilloma virus (HPV) infection, especially persistent infection with type 16 (HPV-16), is known to be the primary etiological factor. Therapeutic vaccines are urgently needed because prophylactic vaccines are ineffective at cle...
Autores principales: | Su, Lin, Zhang, Yunwen, Zhang, Xiang, Liu, Ting, Liu, Sijing, Li, Yongyu, Jiang, Mingjuan, Tang, Tian, Shen, Haiqian, Wang, Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238941/ https://www.ncbi.nlm.nih.gov/pubmed/34183739 http://dx.doi.org/10.1038/s41598-021-92875-9 |
Ejemplares similares
-
An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression
por: Rice, Adrian E, et al.
Publicado: (2015) -
Hemolysin function of Listeria is related to biofilm formation: transcriptomics analysis
por: Li, Ruidan, et al.
Publicado: (2022) -
Design of a Highly Effective Therapeutic HPV16 E6/E7-Specific DNA Vaccine: Optimization by Different Ways of Sequence Rearrangements (Shuffling)
por: Almajhdi, Fahad N., et al.
Publicado: (2014) -
A Genetically Modified attenuated Listeria Vaccine Expressing HPV16 E7 Kill Tumor Cells in Direct and Antigen-Specific Manner
por: Jia, Yan Yan, et al.
Publicado: (2017) -
A Non-oncogenic HPV 16 E6/E7 Vaccine Enhances Treatment of HPV Expressing Tumors
por: Wieking, Bryant G., et al.
Publicado: (2012)